STOCKHOLDERS' EQUITY

6 Months Ended

Jul. 31, 2024

STOCKHOLDERS' EQUITY

STOCKHOLDERS' EQUITY

NOTE 13 – STOCKHOLDERS’ EQUITY

During the six months ended July 31, 2024, the Company’s board of directors declared two regular quarterly cash dividends, each in the amount of $0.30 per share of common stock, which were paid to stockholders on April 22, 2024 and July 31, 2024. During the six months ended July 31, 2023, the Company’s board of directors declared two regular quarterly cash dividends, each in the amount of $0.25 per share of common stock, which were paid to stockholders on April 28, 2023 and July 31, 2023.

Pursuant to its established program and authorizations provided by Argan’s board of directors, the Company repurchased shares of its common stock during the six months ended July 31, 2024 and 2023 and added the shares to treasury stock. During these periods, the Company repurchased 5,600 shares and 169,788 shares of common stock, all on the open market, for aggregate prices of approximately $0.3 million, or $44.87 per share, and $6.7 million, or $39.45 per share, respectively.

For the six months ended July 31, 2024, the Company accepted 417,431 shares of common stock at the average price per share of $68.04 for the exercise price and/or tax withholding in connection with stock option exercises and other share-based award settlements. For the six months ended July 31, 2023, the Company did not accept any shares of common stock for such transactions. For the six months ended July 31, 2024 and 2023, the Company used 260,630 shares and 81,851 shares of treasury stock, respectively, to settle stock option exercises and other share-based awards.